Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-10 | New | $21,500,000 | $21,500,000 | Equity Only | 06b | SEC link |
| 2018-11-19 | New | $93,432,873 | $93,432,873 | Equity Only | 06b | SEC link |
| 2016-01-11 | New | $15,000,000 | $15,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Anne Borgman | Director |
| Steven P. Cobourn | Executive |
| Ellen G. Feigal | Director |
| Carolyn Green | Director |
| Udayan Guha | Executive |
| Kevin N. Heller | Executive |
| John G. Houston | Director |
| Elaine V. Jones | Director |
| David Kabakoff | Director |
| Chau Q. Khuong | Director |
| Sourav Kundu | Executive |
| Judith Li | Director |
| Timothy Mayer | Executive |
| Michael Richman | Director, Executive |
| Asher Rubin | Executive |
| Tim Shannon | Director |
| Kevin Shaw | Executive |
| Stephen Webster | Director |
| Stella Xu | Director |
| Michael Yi | Director |